Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study

By Steenholdt Casper   Molazahi Akbar   Ainsworth Mark Andrew   Brynskov Jørn   Thomsen Ole Østergaard   Seidelin Jakob Benedict  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 5, 2012-05 ,pp. : 518-527

Informa Healthcare

Access to resources Recommend Favorite

IBS-Like Symptoms in Patients with Inflammatory Bowel Disease in Remission; Relationships with Quality of Life and Coping Behavior

By Minderhoud Itta M.   Oldenburg Bas   Wismeijer Josta A.   Van Berge Henegouwen Gerard P.   Smout André J.P.M.  

Digestive Diseases and Sciences, Vol. 49, Iss. 3, 2004-03 ,pp. : 469-474

Springer Publishing Company

Access to resources Recommend Favorite

A Pilot Study on Chemospecific Duodenal Visceral Sensitivity in Inflammatory Bowel Disease in Remission

By  

Digestion, Vol. 73, Iss. 2-3, 2006-07 ,pp. : 151-159

Karger

Access to resources Recommend Favorite

Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients

By Keegan Denise   McDermott Edel   Byrne Kathryn   Moloney David   Doherty Glen A   Mulcahy Hugh E  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 2, 2013-02 ,pp. : 183-188

Informa Healthcare

Access to resources Recommend Favorite

Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study

By  

Digestion, Vol. 85, Iss. 1, 2011-11 ,pp. : 1-8

Karger

Access to resources Recommend Favorite